-
-
2022/05/24 The shelf life of Lantyng Antrodia Cinnamomea Mycelium Capsules has been extended to 36 months.
-
2022/03/25 "2022 Nutrition and Health Food Innovation Award for outstanding model corporation" Awards ceremony in Ingredients and Products on Precision Nutrition Trends.
-
2022/01/25 Economic Daily NEWS: "Lantyng Antrodia Cinnamomea Mycelium Capsules" are approved by the FDA in Taiwan that uses Antrodia cinnamomea to "Blood sugar regulation".
-
2022/01/17 The Tenth Anniversary of Lanting Biotechnology. SPECIAL OFFER!
-
2021/12/29 CNEWS: "Lantyng Antrodia Cinnamomea Mycelium Capsules" are approved by the FDA in Taiwan that uses Antrodia cinnamomea to "Blood sugar regulation".
-
2021/12/08 Approved by the FDA in Taiwan that uses Antrodia cinnamomea to "Blood sugar regulation":衛部健食字第A00411號
-
-
11/23 Attend the 2018 National Biotechnology and Health Industry Symposium
-
06/11 Taiwan Patent of antrocamol: Patent No. I626053
-
02/05 2018 Nutrition and Health Food Innovation Award (HEALTH FOOD SOCIETY OF TAIWAN) for outstanding model corporation.
-
01/18 China Patent of antrocamol: Patent No. ZL201410080982.X
-
12/08 Lantyng Biotechnology Corp. joined the exhibition of third cross strait (Hefei) health pension Industry Cooperation Forum in Chaohu City, Anhui Province, China.
-
10/16 "Mycelium extract of solid-state cultured AC", were approved by TFDA.
-
10/02 NEW Arrivial! Skin Care -Moisturizing Repair "Antrocamol Cream".
-
09/25 NEW Arrivial! Food Supplement -Health Maintenance "Lantyng Antrodia Cinnamomea Mycelium Capsule".
-
08/23 Dr. Maotien Kuo gave a Career guidance lecture for Students in the National Defense Medical Center (Institute of Biochemistry).
-
07/13 Lantyng Got a government fee subsidy from Small Business Innovation Research (SBIR) program
-
05/06 Publication: Molecules. 2017, 22(5), 747.
-
04/19 Lantyng Antrodia cinnamomea ingredients, "Mycelium powder of solid-state cultured AC", were approved by TFDA.
-
04/18 U.S. Patent of antrocamol: Patent No. US 9,622,990 B2
-
03/20 Taiwan Patent of antrocamol: Patent No. I583376
-
02/11 Taiwan Patent of antrocamol: Patent No. I569797
-
10/05 U.S. Patent of antrocamol: Patent No. US 9,474,775 B2
-
10/01 Lantyng Biotechnology Corp. have removed to the following address.
-
08/11 China Patent of antrocamol: Patent No. ZL201310204312.X
-
06/27 Lantyng Biotech Corp. has completed two 90-day toxicity study report.
-
06/23 Taiwan Patent of antrocamol: Patent No. I543760
-
-
-
-
-
-
06/12 Publication: Chinese Journal of Experimental Traditional Medical Formulae.
-
02/23 Publication: Fitoterapia. 2015,102:115-119.
-
01/28 Taiwan Patent of antrocamol: Patent No. I466677
-
11/02 Lantyng Biotechnology Corp. joined the exhibition of 17th International Congress of Oriental Medicine in Taipei.
-
11/01 Industry-university cooperative research project.
-
08/14 Lantyng Biotechnology Corp. joined the exhibition of 10th International Postgraduate Symposium on Chinese Medicine in Hong Kong.
-
10/28 China Trademark Certificate: Antrocamol.
-
12/25 Taiwan Trademark Certificate: Antrocamol.
-
11/10 Lantyng Biotechnology Corp. joined the exhibition of 3th World Congress of Chinese Medicine in Nanjing.
-
10/01 Academic Exchange with Globally renowned universities.